Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top
Weight-loss drugmakers report strong earnings: Boon or bane?
Views 122K Contents 246

The $Tempest Therapeutics (TPST.US)$ story. 1.Need at leas...

1.Need at least 50M with a partnership for a phase 3 study, if no partnership well then they need $100M.

2. Aren't able to rasie no where near this amount due to Ib6 restrictions so need to close the price high enough to get IB1

3.Acheive IB1 by squeezing the life out of everyone then announce some form of offering the next day to raise money for upcoming studies

It's not rocket science. Look past the smoke and mirrors of news and ask the real question "whats the real reason they are they moving this today?"

Helps you not just avoid the short but also you may be more long biased.
The $Tempest Therapeutics (TPST.US)$ story.   1.Need at least 50M with a partnership for a phase 3 study, if no partnership well then they need $100M.   2. Aren...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
+0
2
Translate
Report
2427 Views
Comment
Sign in to post a comment
342Followers
6Following
1000Visitors
Follow